US$19bn of global insured losses in H1 2019: Swiss Re
August 16 2019 by Andrew Tjaardstra
-
Emerging Asia may benefit from US tariffs as China suffers: Swiss Re’s Haegeli
- November 21
Tariffs, taxes, and a decrease in trade could be a tipping point for the wider industry as there are many uncertainties around future US presidential decisions, said the reinsurer's group chief economist.
-
Rokstone launches global multi-peril parametric offering with US$10m facility
- November 20
The MGA has partnered with NormanMax Lloyd’s Syndicate 3939 to launch to cover earthquake, hurricane, tropical cyclone and typhoon risks, with further perils including floods set to be added next year.
-
PCRIC secures US$2.6m grant from Global Shield Solutions Platform
- November 18
The funding from the climate change-focused multi-donor grant facility will be used to support product, development, research, education and eventually, scholarships.
-
NZ non-life segment growth to remain robust even as carriers adjust rates: AM Best
- November 11
In its latest report on the segment, the rating agency has maintained a stable outlook citing solid premium growth supported by rate adjustments.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
